cyclohexanol has been researched along with n-desmethylvenlafaxine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cherkaoui, S; Rudaz, S; Veuthey, JL | 1 |
| Bengtsson, F; Björk, H; Lundmark, J; Reis, M | 1 |
| Fosaas, K; Hendset, M; Hermann, M; Hjerpset, M; Refsum, H | 1 |
| Launiainen, T; Ojanperä, I; Rasanen, I; Vuori, E | 1 |
| Ahlner, J; Bengtsson, F; Carlsson, B; Josefsson, M; Karlsson, L; Kingbäck, M; Kugelberg, FC | 1 |
| Bonato, PS; da Fonseca, P | 1 |
| Boillot, C; Casellas, C; Fenet, H; Gómez, E; Martínez Bueno, MJ; Munaron, D | 1 |
| Eliasson, E; Haslemo, T; Lindh, JD; Mannheimer, B; Molden, E | 1 |
| Domingues, DS; Miranda, LF; Queiroz, ME | 1 |
| Buszewsk, B; Gajewski, J; Karakula-Juchnowicz, H; Morylowska-Topolska, J; Petruczynik, A; Szultka-Mlynska, M; Waksmundzka-Hajnosi, M; Wroblewski, K | 1 |
| Eliasson, E; Haslemo, T; Ingelman-Sundberg, M; Jukić, MM; Molden, E | 1 |
| Barabás-Hajdu, E; Budău, M; Hancu, G; Lupu, D; Milan, A | 1 |
1 review(s) available for cyclohexanol and n-desmethylvenlafaxine
| Article | Year |
|---|---|
Enantioselective analysis of venlafaxine and its active metabolites: A review on the separation methodologies.
Topics: Antidepressive Agents; Chromatography, Liquid; Cyclohexanols; Desvenlafaxine Succinate; Electrophoresis, Capillary; Humans; Stereoisomerism; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2021 |
11 other study(ies) available for cyclohexanol and n-desmethylvenlafaxine
| Article | Year |
|---|---|
Nonaqueous capillary electrophoresis-mass spectrometry for separation of venlafaxine and its phase I metabolites.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Desvenlafaxine Succinate; Electrophoresis, Capillary; Molecular Structure; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2001 |
Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Male; Middle Aged; Sex Factors; Smoking; Stereoisomerism; Venlafaxine Hydrochloride | 2002 |
Serum concentrations of venlafaxine and its metabolites O-desmethylvenlafaxine and N-desmethylvenlafaxine in heterozygous carriers of the CYP2D6*3, *4 or *5 allele.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Female; Genotype; Heterozygote; Humans; Male; Middle Aged; Retrospective Studies; Venlafaxine Hydrochloride | 2008 |
Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Databases, Factual; Desvenlafaxine Succinate; Drug Interactions; Female; Forensic Pathology; Gas Chromatography-Mass Spectrometry; Genotype; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2011 |
Stereoselective determination of venlafaxine and its three demethylated metabolites in human plasma and whole blood by liquid chromatography with electrospray tandem mass spectrometric detection and solid phase extraction.
Topics: Chromatography, Liquid; Cyclohexanols; Desvenlafaxine Succinate; Drug Stability; Humans; Selective Serotonin Reuptake Inhibitors; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Venlafaxine Hydrochloride | 2010 |
Hollow-fiber liquid-phase microextraction and chiral LC-MS/MS analysis of venlafaxine and its metabolites in plasma.
Topics: 1-Octanol; Antidepressive Agents, Second-Generation; Calibration; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Hydrogen-Ion Concentration; Liquid Phase Microextraction; Stereoisomerism; Tandem Mass Spectrometry; Venlafaxine Hydrochloride | 2013 |
Occurrence of venlafaxine residues and its metabolites in marine mussels at trace levels: development of analytical method and a monitoring program.
Topics: Animals; Biotransformation; Bivalvia; Chromatography, Liquid; Cyclohexanols; Humans; Mass Spectrometry; Mediterranean Sea; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2014 |
Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Child; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Paliperidone Palmitate; Predictive Value of Tests; Retrospective Studies; Risperidone; Sensitivity and Specificity; Venlafaxine Hydrochloride; Young Adult | 2016 |
Selective solid-phase extraction using molecularly imprinted polymers for analysis of venlafaxine, O-desmethylvenlafaxine, and N-desmethylvenlafaxine in plasma samples by liquid chromatography-tandem mass spectrometry.
Topics: Acrylates; Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclohexanols; Depression; Desvenlafaxine Succinate; Humans; Methacrylates; Microscopy, Electron, Scanning; Molecular Imprinting; Nitriles; Polymerization; Polymers; Solid Phase Extraction; Spectroscopy, Fourier Transform Infrared; Tandem Mass Spectrometry; Toluene; Venlafaxine Hydrochloride | 2016 |
DETERMINATION OF VENLAFAXINE, VILAZODONE AND THEIR MAIN ACTIVE METABOLITES IN HUMAN SERUM BY HPLC-DAD AND HPLC-MS.
Topics: Antidepressive Agents; Biotransformation; Calibration; Chromatography, High Pressure Liquid; Cyclohexanols; Humans; Limit of Detection; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Venlafaxine Hydrochloride; Vilazodone Hydrochloride | 2017 |
Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients.
Topics: Aged; Alleles; Antidepressive Agents, Second-Generation; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Drug Monitoring; Female; Genotype; Humans; Male; Middle Aged; Norway; Retrospective Studies; Venlafaxine Hydrochloride | 2019 |